Cardiologs co-founder and CEO Yann Fleureau was named the European Innovator of the Year by MIT Technology Review, which also included the French native on its list of the top 35 European innovators under the age of 35.
The FDA is speeding up the review process for new software that uses AI to help radiologists diagnose chronic thromboembolic pulmonary hypertension (CTEPH), pharmaceutical company Bayer announced Dec. 3.
A deep-learning algorithm was significantly faster and just as accurate as most radiologists in analyzing chest X-rays for several diseases, according to a study led by Stanford University researchers.
An AI-based network outperformed several dermatologists while analyzing skin lesions for cancer, suggesting the technology could be a helpful tool for physicians regardless of their experience, according to a recent study.
Saint Thomas Health, a Tennessee-based health system, is the first in the state to use an AI-based software system that helps clinicians better diagnose and treat coronary artery disease, according to an online report by WGNS News Radio.
Deep-learning models trained to detect pneumonia from chest X-rays performed worse when tested on X-rays from outside their original hospital systems, suggesting AI tools should undergo a wide range of testing before being used in clinical settings.